Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.
Kemps PG, Woei-A-Jin FJSH, Schöffski P, Tousseyn T, Vanden Bempt I, Meyer-Wentrup FAG, Dors N, van Eijkelenburg NKA, Scheijde-Vermeulen MA, Jazet IM, Limper M, Jak M, Verdijk RM, Donker ML, de Jonge NA, van Noesel CJM, Hebeda KM, van Dorp S, Tonino SH, van Laar JAM, van den Bos C, van Halteren AGS; HOVON Histiocytic and Lymphocytic Diseases Working Group. Kemps PG, et al. Among authors: limper m. Blood Neoplasia. 2024 Jun 10;1(3):100023. doi: 10.1016/j.bneo.2024.100023. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40453055 Free PMC article.
Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
van Schaik M, Arends EJ, Soonawala D, van Ommen E, de Leeuw K, Limper M, van Paassen P, Huizinga TWJ, Toes REM, van Kooten C, Rotmans JI, Rabelink TJ, Teng YKO. van Schaik M, et al. Among authors: limper m. Trials. 2022 Nov 12;23(1):939. doi: 10.1186/s13063-022-06874-w. Trials. 2022. PMID: 36371234 Free PMC article.
Recurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study.
Bhoelan S, Borjas Howard J, Tichelaar V, van Daele P, Hak L, Voskuyl A, Limper M, Goekoop R, Teng O, Vosters J, Bijl M, Zirkzee E, Schilder A, Bernelot Moens H, de Leeuw K, Meijer K. Bhoelan S, et al. Among authors: limper m. Res Pract Thromb Haemost. 2022 Nov 14;6(8):e12839. doi: 10.1002/rth2.12839. eCollection 2022 Nov. Res Pract Thromb Haemost. 2022. PMID: 36397932 Free PMC article.
Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-β2-glycoprotein I antibody titers.
Noordermeer T, Urbanus RT, Wong CY, Jansma JJ, Wiersma NM, Zivkovic M, Huisman A, Limper M. Noordermeer T, et al. Among authors: limper m. Res Pract Thromb Haemost. 2022 Dec 12;7(1):100011. doi: 10.1016/j.rpth.2022.100011. eCollection 2023 Jan. Res Pract Thromb Haemost. 2022. PMID: 36891523 Free PMC article.
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations.
Arnaud L, Ruiz-Irastorza G, Aranow C, Bernatsky S, Dall'Era M, Adelowo O, Bae SC, Beretta L, Bonfa E, Cervera R, Chasset F, Clarke AE, Costedoat-Chalumeau N, Doria A, Espinosa G, Fanouriakis A, Fredi M, Gatto M, Gladman DD, Gomez-Puerta JA, Inanç M, Ines LS, Isenberg D, Izuka S, Khmelinskii N, Legge A, Macieira C, Monticielo OA, Morand EF, Muñoz-Louis R, Padjen I, Petri M, Piga M, Pons-Estel BA, Ramirez GA, Ramsey-Goldman R, Richez C, Sciascia S, Toro-Gutierrez CE, Van Vollenhoven RF, Vital EM, Gerosa M, Touma Z, Mosca M, Tani C; European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal, Diseases; Systemic Lupus Erythematosus International Collaborating Clinics group; European Lupus Society rare systemic lupus erythematosus taskforce member panel. Arnaud L, et al. Lancet Rheumatol. 2025 Jul;7(7):e505-e518. doi: 10.1016/S2665-9913(25)00063-3. Epub 2025 May 23. Lancet Rheumatol. 2025. PMID: 40418946 Review.
151 results